Literature DB >> 30202610

Evaluation of Corneal Biomechanical Changes After Collagen Crosslinking in Patients with Progressive Keratoconus by Ocular Response Analyzer.

Raciha Beril Küçümen1, Berna Şahan1, Canan Aslı Yıldırım2, Ferda Çiftçi1.   

Abstract

OBJECTIVES: To evaluate corneal biomechanics before and after collagen crosslinking (CXL) in patients with progressive keratoconus.
MATERIALS AND METHODS: In this prospective study, CXL was performed under topical anesthesia after removal of the epithelium (epi-off technique) by applying ultraviolet A (UVA) light at a wavelength of 365 nm and power of 3 mW/cm2 or 5.4 joule/cm2. Isoosmolar 0.1% riboflavin solution was administered before and during UVA irradiation. In addition to ophthalmologic examination, ocular response analyzer measurements were performed pre- and postoperatively. Corneal hysteresis (CH), corneal resistance factor (CRF), corneal compensated intraocular pressure (IOPcc), Goldmann-correlated intraocular pressure (IOPg), and central corneal thickness (CCT) were recorded.
RESULTS: The study included 35 eyes of 30 patients with progressive keratoconus. The mean age was 28.2±6.5 years and postoperative follow-up time was 20.2±14.7 months (range: 6-74 months). The mean CH was 8.60±1.23 mmHg preoperatively, 8.96±2.05 mmHg in the early postoperative period (1-6 months), (p=0.28) and 8.96±1.28 mmHg in the late postoperative period (10-29 months) (p=0.48). Mean CRF was 7.13±1.50 mmHg preoperatively, 8.48±2.16 mmHg in the early postoperative period (p=0.009), and 7.71±1.29 mmHg in the late postoperative period (p=0.40). Mean IOPcc was 12.78±2.34 mmHg preoperatively, 15.38±4.21 mmHg in the early postoperative period (p=0.12) and 13.68±3.61 mmHg in the late postoperative period (p=0.48). Mean IOPg was 9.56±2.73 mmHg preoperatively, 13.01±4.45 mmHg in the early postoperative period (p=0.046), and 10.86±3.47 mmHg in the late postoperative period (p=0.44). Mean CCT was 484.43±41.26 µm preoperatively, 474.16±64.74 µm in the early postoperative period (p=0.70), and 470.38±33.64 µm in late postoperative period (p=0.71).
CONCLUSION: CXL is a treatment modality believed to affect corneal biomechanics in keratoconus, but the results of larger patient series with longer follow-up periods may enable a better evaluation.

Entities:  

Keywords:  Keratoconus; collagen crosslinking; corneal biomechanics

Year:  2018        PMID: 30202610      PMCID: PMC6126096          DOI: 10.4274/tjo.56750

Source DB:  PubMed          Journal:  Turk J Ophthalmol        ISSN: 2149-8709


  32 in total

1.  Determining in vivo biomechanical properties of the cornea with an ocular response analyzer.

Authors:  David A Luce
Journal:  J Cataract Refract Surg       Date:  2005-01       Impact factor: 3.351

2.  Detection of biomechanical changes after corneal cross-linking using Ocular Response Analyzer software.

Authors:  Eberhard Spoerl; Naim Terai; Freia Scholz; Frederik Raiskup; Lutz E Pillunat
Journal:  J Refract Surg       Date:  2011-01-17       Impact factor: 3.573

3.  Clinical and corneal biomechanical changes after collagen cross-linking with riboflavin and UV irradiation in patients with progressive keratoconus: results after 2 years of follow-up.

Authors:  Yakov Goldich; Arie L Marcovich; Yaniv Barkana; Yossi Mandel; Ami Hirsh; Yair Morad; Isaac Avni; David Zadok
Journal:  Cornea       Date:  2012-06       Impact factor: 2.651

4.  Intra- and postoperative variation in ocular response analyzer parameters in keratoconic eyes after corneal cross-linking.

Authors:  Paolo Vinciguerra; Elena Albè; Ashraf M Mahmoud; Silvia Trazza; Farhad Hafezi; Cynthia J Roberts
Journal:  J Refract Surg       Date:  2010-04-15       Impact factor: 3.573

5.  In vivo biomechanical changes after corneal collagen cross-linking for keratoconus and corneal ectasia: 1-year analysis of a randomized, controlled, clinical trial.

Authors:  Steven A Greenstein; Kristen L Fry; Peter S Hersh
Journal:  Cornea       Date:  2012-01       Impact factor: 2.651

6.  Increased corneal hysteresis after corneal collagen crosslinking: a study based on applanation resonance technology.

Authors:  Jeannette Beckman Rehnman; Anders Behndig; Per Hallberg; Christina Lindén
Journal:  JAMA Ophthalmol       Date:  2014-12       Impact factor: 7.389

7.  Corneal hysteresis measured with the Ocular Response Analyzer in normal and glaucomatous eyes.

Authors:  Olivia Abitbol; Jihène Bouden; Serge Doan; Thanh Hoang-Xuan; Damien Gatinel
Journal:  Acta Ophthalmol       Date:  2009-11-05       Impact factor: 3.761

8.  Changes in the quality-of-life of people with keratoconus.

Authors:  Steven M Kymes; Jeffrey J Walline; Karla Zadnik; John Sterling; Mae O Gordon
Journal:  Am J Ophthalmol       Date:  2008-01-28       Impact factor: 5.258

9.  Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking.

Authors:  Gregor Wollensak; Eberhard Spoerl; Theo Seiler
Journal:  J Cataract Refract Surg       Date:  2003-09       Impact factor: 3.351

10.  Intraocular Pressure Measurements Referring to the Corneal Thickness in Keratoconic Eyes After Corneal Crosslinking with Riboflavin and Ultraviolet A.

Authors:  Sanja Sefic Kasumovic; Milka Mavija; Aida Kasumovic; Orhan Lepara; Belkisa Duric-Colic; Emir Cabric; Lejla Muhamedagic; Adisa Sakovic-Racic; Mirko Jankov
Journal:  Med Arch       Date:  2015-10-04
View more
  3 in total

1.  Superiority of Baseline Biomechanical Properties over Corneal Tomography in Predicting Keratoconus Progression

Authors:  Mehmet Akif Erol; Eray Atalay; Onur Özalp; Abdullah Divarcı; Nilgün Yıldırım
Journal:  Turk J Ophthalmol       Date:  2021-10-26

2.  Alterations in Corneal Biomechanical and Topographic Features After Accelerated Crosslinking: 1-Year Results.

Authors:  Ahmet Kirgiz; Sevil Karaman Erdur; Kubra Serefoglu Cabuk; Kursat Atalay; Senay Asik Nacaroglu
Journal:  Beyoglu Eye J       Date:  2019-08-08

3.  The Mechanical Interpretation of Ocular Response Analyzer Parameters.

Authors:  Xiao Qin; Mengyao Yu; Haixia Zhang; Xinyan Chen; Lin Li
Journal:  Biomed Res Int       Date:  2019-07-16       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.